|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Dessí S, Batetta B, Anchisi C, Pani P,
Costelli P, Tessitore L and Baccino FM: Cholesterol metabolism
during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J
Cancer. 66:787–793. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dessì S, Batetta B, Pulisci D, Spano O,
Anchisi C, Tessitore L, Costelli P, Baccino FM, Aroasio E and Pani
P: Cholesterol content in tumor tissues is inversely associated
with high-density lipoprotein cholesterol in serum in patients with
gastrointestinal cancer. Cancer. 73:253–258. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolanjiappan K, Ramachandran CR and
Manoharan S: Biochemical changes in tumor tissues of oral cancer
patients. Clin Biochem. 36:61–65. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rudling M and Collins VP: Low density
lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A
reductase mRNA levels are coordinately reduced in human renal cell
carcinoma. Biochim Biophys Acta. 1299:75–79. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schaffner CP: Prostatic cholesterol
metabolism: Regulation and alteration. Prog Clin Biol Res.
75A:279–324. 1981.PubMed/NCBI
|
|
7
|
Yoshioka Y, Sasaki J, Yamamoto M, Saitoh
K, Nakaya S and Kubokawa M: Quantitation by (1)H-NMR of dolichol,
cholesterol and choline-containing lipids in extracts of normal and
phathological thyroid tissue. NMR Biomed. 13:377–383. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Järvinen R, Knekt P, Hakulinen T, Rissanen
H and Heliövaara M: Dietary fat, cholesterol and colorectal cancer
in a prospective study. Br J Cancer. 85:357–361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Caruso MG, Notarnicola M, Santillo M,
Cavallini A and Di Leo A: Enhanced 3-hydroxy-3-methyl-glutaryl
coenzyme A reductase activity in human colorectal cancer not
expressing low density lipoprotein receptor. Anticancer Res.
19:451–454. 1999.PubMed/NCBI
|
|
10
|
Caruso MG, Notarnicola M, Cavallini A and
Di Leo A: 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity
and low-density lipoprotein receptor expression in diffuse-type and
intestinal-type human gastric cancer. J Gastroenterol. 37:504–508.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Notarnicola M, Messa C, Pricci M, Guerra
V, Altomare DF, Montemurro S and Caruso MG: Up-regulation of
3-hydroxy-3-methylglutaryl coenzyme A reductase activity in
left-sided human colon cancer. Anticancer Res. 24:3837–3842.
2004.
|
|
12
|
Gregg RG, Davidson M and Wilce PA:
Cholesterol synthesis and HMG CoA reductase activity during
hepatocarcinogenesis in rats. Int J Biochem. 18:389–393. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hentosh P, Yuh SH, Elson CE and Peffley
DM: Sterol-independent regulation of 3-hydroxy-3-methylglutaryl
coenzyme A reductase in tumor cells. Mol Carcinog. 32:154–166.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siperstein MD: Cholesterol,
cholesterogenesis and cancer. Adv Exp Med Biol. 369:155–166. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Graziani SR, Igreja FA, Hegg R, Meneghetti
C, Brandizzi LI, Barboza R, Amâncio RF, Pinotti JA and Maranhão RC:
Uptake of a cholesterol-rich emulsion by breast cancer. Gynecol
Oncol. 85:493–497. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schimanski S, Wild PJ, Treeck O, Horn F,
Sigruener A, Rudolph C, Blaszyk H, Klinkhammer-Schalke M, Ortmann
O, Hartmann A, et al: Expression of the lipid transporters ABCA3
and ABCA1 is diminished in human breast cancer tissue. Horm Metab
Res. 42:102–109. 2010. View Article : Google Scholar
|
|
17
|
Tatidis L, Masquelier M and Vitols S:
Elevated uptake of low density lipoprotein by drug resistant human
leukemic cell lines. Biochem Pharmacol. 63:2169–2180. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Basso K, Margolin AA, Stolovitzky G, Klein
U, Dalla-Favera R and Califano A: Reverse engineering of regulatory
networks in human B cells. Nat Genet. 37:382–390. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ki DH, Jeung HC, Park CH, Kang SH, Lee GY,
Lee WS, Kim NK, Chung HC and Rha SY: Whole genome analysis for
liver metastasis gene signatures in colorectal cancer. Int J
Cancer. 121:2005–2012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moustafa MA, Ogino D, Nishimura M, Ueda N,
Naito S, Furukawa M, Uchida T, Ikai I, Sawada H and Fukumoto M:
Comparative analysis of ATP-binding cassette (ABC) transporter gene
expression levels in peripheral blood leukocytes and in liver with
hepatocellular carcinoma. Cancer Sci. 95:530–536. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Attie AD: ABCA1: At the nexus of
cholesterol, HDL and atherosclerosis. Trends Biochem Sci.
32:172–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim VN: Small RNAs: Classification,
biogenesis, and function. Mol Cells. 19:1–15. 2005.PubMed/NCBI
|
|
24
|
Najafi-Shoushtari SH, Kristo F, Li Y,
Shioda T, Cohen DE, Gerszten RE and Näär AM: MicroRNA-33 and the
SREBP host genes cooperate to control cholesterol homeostasis.
Science. 328:1566–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramirez CM, Dávalos A, Goedeke L, Salerno
AG, Warrier N, Cirera-Salinas D, Suárez Y and Fernández-Hernando C:
MicroRNA-758 regulates cholesterol efflux through
posttranscriptional repression of ATP-binding cassette transporter
A1. Arterioscler Thromb Vasc Biol. 31:2707–2714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramírez CM, Rotllan N, Vlassov AV, Dávalos
A, Li M, Goedeke L, Aranda JF, Cirera-Salinas D, Araldi E, Salerno
A, et al: Control of cholesterol metabolism and plasma high-density
lipoprotein levels by microRNA-144. Circ Res. 112:1592–1601. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Subramanian S, Lui WO, Lee CH, Espinosa I,
Nielsen TO, Heinrich MC, Corless CL, Fire AZ and van de Rijn M:
MicroRNA expression signature of human sarcomas. Oncogene.
27:2015–2026. 2008. View Article : Google Scholar
|
|
30
|
Sarver AL, Phalak R, Thayanithy V and
Subramanian S: S-MED: Sarcoma microRNA expression database. Lab
Invest. 90:753–761. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Calin GA, Cimmino A, Fabbri M, Ferracin M,
Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI,
et al: miR-15a and miR-16-1 cluster functions in human leukemia.
Proc Natl Acad Sci USA. 105:5166–5171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang XW, Xi XQ, Wu J, Wan YY, Hui HX and
Cao XF: Micro-RNA-206 attenuates tumor proliferation and migration
involving the downregulation of NOTCH3 in colorectal cancer. Oncol
Rep. 33:1402–1410. 2015.PubMed/NCBI
|
|
37
|
Bekker-Méndez C, Guzmán-Aguilar RM,
Hernández-Cueto MA, Huerta-Yepez S, Jarillo-Luna RA,
González-Veyrand E and González-Bonilla CR: TUNEL-positive cells in
the surgical border of an amputation due to infected diabetic foot.
Mol Med Rep. 5:363–372. 2012.
|
|
38
|
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y,
Wang Z, Wang Z, Cheng P, Tong D, et al: MicroRNA-133a,
downregulated in osteosarcoma, suppresses proliferation and
promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 56:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: microRNA-143, down-regulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
40
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian microRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
46
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Heresbach D, Manfredi S, D'halluin PN,
Bretagne JF and Branger B: Review in depth and meta-analysis of
controlled trials on colorectal cancer screening by faecal occult
blood test. Eur J Gastroenterol Hepatol. 18:427–433. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Oram JF and Lawn RM: ABCA1. The gatekeeper
for eliminating excess tissue cholesterol. J Lipid Res.
42:1173–1179. 2001.PubMed/NCBI
|
|
50
|
Kennedy MA, Barrera GC, Nakamura K, Baldán
A, Tarr P, Fishbein MC, Frank J, Francone OL and Edwards PA: ABCG1
has a critical role in mediating cholesterol efflux to HDL and
preventing cellular lipid accumulation. Cell Metab. 1:121–131.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Solomon KR, Allott EH, Freeman MR and
Freedland SJ: Words of wisdom. Re: Dysregulation of cholesterol
homeostasis in human prostate cancer through loss of ABCA1. Eur
Urol. 63:1128–1129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liang Z, Gao Y, Shi W, Zhai D, Li S, Jing
L, Guo H, Liu T, Wang Y and Du Z: Expression and significance of
microRNA-183 in hepatocellular carcinoma. Scientific World Journal.
2013:3818742013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ueno K, Hirata H, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL, Hinoda Y and Dahiya R: microRNA-183 is an
oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br J Cancer.
108:1659–1667. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J,
Qin Y, Sun Z and Zheng X: miR-183 inhibits TGF-beta1-induced
apoptosis by downregulation of PDCD4 expression in human
hepatocellular carcinoma cells. BMC Cancer. 10:3542010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhou T, Zhang GJ, Zhou H, Xiao HX and Li
Y: Overexpression of microRNA-183 in human colorectal cancer and
its clinical significance. Eur J Gastroenterol Hepatol. 26:229–233.
2014. View Article : Google Scholar
|
